Abstract GMM-057: A FUNCTIONAL HOMOLOGOUS RECOMBINATION ASSAY PREDICTS PRIMARY CHEMOTHERAPY RESPONSE AND LONG-TERM SURVIVAL IN OVARIAN CANCER PATIENTS

2019 ◽  
Author(s):  
Manuela Tumiati ◽  
Sakari Hietanen ◽  
Johanna Hynninen ◽  
Elina Pietilä ◽  
Anniina Färkkilä ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Homologous Recombination ◽  
Cancer Patients ◽  
Primary Chemotherapy ◽  
Chemotherapy Response ◽  
Term Survival ◽  
Long Term Survival ◽  
Recombination Assay

Does neoadjuvant chemotherapy impair long-term survival for ovarian cancer patients? A nationwide Danish study

2014 ◽  
Vol 132 (2) ◽  
pp. 292-298 ◽  
Author(s):  
Carsten Lindberg Fagö-Olsen ◽  
Bent Ottesen ◽  
Henrik Kehlet ◽  
Sofie L. Antonsen ◽  
Ib J. Christensen ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Cancer Patients ◽  
Term Survival ◽  
Long Term Survival ◽  
Danish Study

scholarly journals Predictors of Long-Term Survival among High-Grade Serous Ovarian Cancer Patients

2019 ◽  
Vol 28 (5) ◽  
pp. 996-999 ◽  
Author(s):  
Christina L. Clarke ◽  
Lawrence H. Kushi ◽  
Jessica Chubak ◽  
Pamala A. Pawloski ◽  
Joanna E. Bulkley ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Patients ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
Term Survival ◽  
Long Term Survival
Sign in / Sign up

Export Citation Format

Share Document